A randomized, double-blind, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis
Annals of Allergy, Asthma, and Immunology Mar 19, 2018
Lieberman JA, et al. - The efficacy of cromolyn in reducing esophageal eosinophilia in patients with eosinophilic esophagitis was assessed herein, with a focus on symptom improvement and adverse effects. No significant attenuation in esophageal eosinophilia resulted from the use of viscous oral cromolyn, however, it did cause reduction in symptom scores (although not significantly more than placebo) and led to complete resolution in one subject.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries